High North Laboratories
“Nordic pharmaceutical excellence in cannabis medicine.”
High North Laboratories is a Norwegian medical cannabis company founded in 2017, developing pharmaceutical-grade cannabis-based medicines from Scandinavian-sourced hemp. High North focuses on CBD-based formulations and supplies the UK medical market.
About High North Laboratories
High North Laboratories was founded in 2017 in Oslo, Norway, leveraging Scandinavia's long tradition of pharmaceutical excellence. The company specialises in developing and producing pharmaceutical-grade, CBD-based cannabis medicines from Norwegian and Scandinavian hemp sources.
High North's production facilities operate under GMP conditions and comply with European pharmaceutical manufacturing standards. Their product range includes standardised CBD oil formulations and investigational cannabis-based medicines targeting neurological and inflammatory conditions.
In the UK medical cannabis market, High North Laboratories' CBD-focused products are available through specialist clinics for patients where high-CBD, low-THC formulations are clinically appropriate. The company's Nordic pharmaceutical heritage and commitment to clinical evidence set them apart in the European cannabis landscape.
Certifications & Standards
EU-GMP Compliant, NOMA Licensed, EMA Aligned
How to Get a Medical Cannabis Prescription
Entirely online — no GP referral needed. Most patients prescribed within 5–10 days.
Medical cannabis is a Schedule 2 controlled drug available on private prescription from GMC-registered specialists.
Full Beginner Guide →